LAG3 and melanoma: We analyzed TCRβ-Seq (anti–LAG-3+anti–PD-1–treated melanoma n = 34, 86 samples; healthy donors n = 783) and scRNA+TCRαβ-Seq (n = 6, 18 samples) data to understand the antigen restriction of expanded T cells.